EligibleTrials

PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Intervention - Study

Recruiting · NCT07621003 · Interventional (participants receive a specific treatment) · Lead sponsor: Asklepios proresearch

View the official record on ClinicalTrials.gov →
Atrial Fibrillation

Interventions studied

Ablation of atrial fibrillation (AF)

What this trial is about

This study is a prospective, multicenter, randomized, open-label, blinded end-point, controlled clinical trial to investigate the impact of first line pulsed field ablation during 12 months follow-up in patients with early-stage paroxysmal or persistent atrial fibrillation (\<3 years) compared to usual care, defined as OMT.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

10 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.